Acadia Healthcare Company, Inc. provides behavioral healthcare services across the United States. Its facilities and services are classified into various categories: acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers (CTCs) and residential treatment centers. Outpatient programs associated with its facilities are included within each respective service line. Its acute inpatient psychiatric facilities provide a high level of care in order to stabilize patients that are either a threat to themselves or to others. Its specialty treatment facilities include residential recovery facilities and eating disorder facilities. It operates over 13 CTC locations in North and South Carolina and 165 locations in 33 states across the country. Its residential treatment centers treat patients with behavioral disorders in a non-hospital setting. The Company operates over 258 behavioral healthcare facilities with 11,400 beds in 38 states and Puerto Rico.
高成長
同社の収益は過去3年間にわたり着実に増加しており、年平均で20.82%の成長率を示しています。
黒字転換
同社は黒字転換を果たし、最新の年間純利益はUSD 255.61Mです。%!(EXTRA int=2)
適正水準
同社の最新のPEは14.56で、過去3年間の水準と比較して適正圏にあります。
機関投資家の売り越し
最新の機関投資家の保有株数は99.48M株で、前四半期比で15.44%減少しています。
バンガードが保有
スター投資家バンガードは本銘柄を8.68M株保有しています。
市場活動が活発
同社への投資家の関心が高まっており、20日間の売買回転率は0.91です。